Sodium Chloride
Product Images NDC 0409-7132

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sodium Chloride (NDC 0409-7132). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sodium 01)

An instructional illustration showing a hand pressing down on a child-proof cap to open a medicine bottle. The image focuses on demonstrating the correct method to remove the bottle cap safely.*

FDA Label Image

Figure 2 (Sodium 02)

An instructional diagram showing the steps to connect or assemble a component involving a tube and a cap, with an upward arrow indicating removal or disconnection of the tube from the assembly.*

FDA Label Image

Figure 3 (Sodium 03)

A black and white line drawing showing a bottle held by a hand. The bottle features a screw cap and a connector or outlet port at the bottom. This illustration likely represents a medical fluid container, such as for intravenous use.*

FDA Label Image

Figure 4 (Sodium 04)

An instructional diagram showing a hand holding a medical fluid bag, with another hand adjusting or securing a cap or connector at the top of the bag. The illustration likely relates to preparation or handling of an intravenous fluid bag, such as Sodium Chloride 900 mg/100 mL, labeled by Hospira, Inc.*

FDA Label Image

Figure 5 (Sodium 05)

An instructional illustration showing a hand holding an IV fluid bag labeled Sodium Chloride 900 mg/100mL and another hand removing a protective seal from the bag's port. The image demonstrates how to prepare the IV bag for use.*

FDA Label Image

Figure 6 (Sodium 06)

An instructional line drawing showing a hand connecting a tube or adapter to an IV bag or medication container. The illustration highlights proper handling or setup technique for intravenous administration equipment, likely related to Sodium Chloride 900 mg/100 mL by Hospira, Inc.*

FDA Label Image

Figure 7 (Sodium 07)

An instructional illustration showing a hand holding an intravenous (IV) infusion bag with a port and tubing attached, depicting the setup for intravenous administration.*

FDA Label Image

Hospira Logo (Sodium 08)

FDA Label Image

Principal Display Panel (50 mL Bag Label)

Label for Sodium Chloride 900 mg/100 mL injection by Hospira, Inc. The label specifies 0.9% sodium chloride concentration in a 50 mL unit. It includes instructions to pull the inner plug/stopper and mix the drug before use. The label also states it is for intravenous use, single-dose container, sterile and nonpyrogenic, with a clear solution and undamaged container requirement.*

FDA Label Image

Principal Display Panel (100 mL Bag Label)

Label for Sodium Chloride 0.9% injection, USP, 900 mg/100 mL by Hospira, Inc. The label specifies 100 mL volume, with instructions to pull the inner plug/stopper and mix the drug before use. It includes electrolyte content details and usage directions for intravenous use only, distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (50 ML AND 100 ML BAG OVERWRAP LABEL – NDC 0409-7101)

Packaging label for Five/ADD-Vantage Units by Hospira, Inc., indicating use only with ADD-Vantage system components. It includes handling instructions about the moisture barrier overwrap, expiration, leak checking, and storage temperature. The label shows distributor details for Hospira, Inc. in Lake Forest, IL.*

FDA Label Image

Principal Display Panel (250 mL Bag Label)

Label for Sodium Chloride 0.9% Injection, USP in a 250 mL solution bag by Hospira, Inc. The label shows the drug concentration as 900 mg per 100 mL with electrolytes information, pH range, and usage instructions. The label also indicates the product is sterile, nonpyrogenic, and for intravenous use only, with a note to mix the drug before use.*

FDA Label Image

Principal Display Panel (250 mL Bag Overwrap Label)

This drug facts panel provides storage and usage instructions for a product designed for use with the ADD-Vantage system. It includes guidance on opening the unit, moisture barrier use, storage temperature (20 to 25°C), and checking for leaks. The label states the product is distributed by Hospira, Inc., in Lake Forest, IL, and is for Rx use only.*

FDA Label Image

Principal Display Panel (50 mL Bag Label)

Label for Sodium Chloride 0.45% Injection, USP, containing 900 mg/100mL, by Hospira, Inc. It includes administration instructions, solution characteristics, and a volume of 50 mL. The label states the product is sterile, nonpyrogenic, single-dose for IV use, and warns to use only if the solution is clear and the container undamaged.*

FDA Label Image

Principal Display Panel (50 mL Bag Overwrap Label)

Label panel for Five/ADD-Vantage Units by Hospira, Inc. The label includes instructions to peel at the notch to open and states use is only with ADD-Vantage system components. It details storage instructions and expiration handling. The Hospira logo and distributor information for Hospira, Inc., Lake Forest, IL are shown. No drug strength or form is visible on this label panel.*

FDA Label Image

Principal Display Panel (250 mL Bag Label)

Label for Sodium Chloride 0.45% Injection, USP, 450 mg per 100 mL, in a 250 mL single-dose container for intravenous use. The label includes instructions to pull the inner plug/stopper and mix before use. Manufactured by Hospira, Inc., the label details electrolyte content, pH, and usage precautions including that the solution is sterile, nonpyrogenic, and contains DEHP and latex components.*

FDA Label Image

Principal Display Panel (250 mL Bag Overwrap Label)

A drug information panel for a unit of ADD-Vantage system indicating it is a moisture barrier overwrap that must be used within 30 days of opening, stored at controlled room temperature (20 to 25°C), and protected from freezing. It advises checking for leaks after removing the overwrap and discarding if leaks are found. The panel includes a note that the unit is for use only with ADD-Vantage system components and is Rx only. The labeler Hospira, Inc. is identified.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.